HOME >> MEDICINE >> NEWS
Drug attacks prostate cancer in mouse model by destroying its blood supply

HOUSTON - A medication used to treat other types of cancer strangles drug-resistant, metastatic prostate cancer by cutting off its blood supply, researchers from The University of Texas M. D. Anderson Cancer Center report in the June 7 issue of the Journal of the National Cancer Institute.

Imatinib, known commercially as Gleevec, worked best when combined with the chemotherapy paclitaxel to slash the incidence of bone metastases and the size of tumors in mice injected with a multiple-drug resistant form of prostate cancer. Tumors were found in only 4 of 18 mice treated with the combination, median tumor weight was one tenth of a gram, and the cancer spread to the lymph nodes in three cases. Tumors grew in all 19 control mice, their median tumor weight was 1.3 grams, and all metastasized to the lymph nodes.

This extremely drug-resistant form of the cancer, designed by the research team to emulate the grim clinical reality of prostate cancer that has spread into the bone, successfully warded off the combined medications in lab experiments, said Isaiah J. Fidler, D.V.M., Ph.D., chair of the Department of Cancer Biology and director of the Cancer Metastasis Research Center at M. D. Anderson.

"Why, then, did it work so well in the animal? Because we didn't attack the tumor, we attacked the blood vessels. We target and destroy the vasculature that provides oxygen and nutrients to tumor cells," said Fidler, the paper's senior author.

Fidler and colleagues show in the JNCI paper that imatinib killed tumor-related blood vessel (endothelial) cells by inactivating the platelet-derived growth factor receptors (PDGF-R) on the cell surface. This prevents the receptor's activation either by PDGF binding to it externally or by a signal generated internally by the cell.

Activation of PDGF-R stimulates the birth of new blood vessels, promotes cell division and migration, and inhibits a protective form of cell suicide known as apoptosis, all h
'"/>

Contact: Scott Merville
sdmervil@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
6-Jun-2006


Page: 1 2 3

Related medicine news :

1. Cognitive therapy can reduce post-traumatic stress in survivors of terrorist attacks
2. New class of HIV drug attacks previously untargeted enzyme
3. Carnegie Mellon professors question advice for nuclear attacks
4. Lack of guidelines on kidney stone attacks could put travel workers and passengers at risk
5. Custom-made cancer cell attacks
6. Drug reduces unscheduled trips to doctor for childhood asthma attacks
7. Aspirin saves lives of cancer patients suffering heart attacks, despite fears of bleeding
8. Statin users risk heart attacks by dropping treatment or taking low doses
9. Timely treatment of heart attacks: Results from the AMI-QUEBEC Study
10. Panic attacks are linked to poor outcomes for diabetic patients, Group Health study finds
11. Blood cells linked to heart attacks, other inflammatory diseases

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/14/2019)... ARCADIA, Ariz. (PRWEB) , ... January 14, 2019 , ... ... Asthma have opened a new clinic in Phoenix, Arcadia Allergy & Asthma. This new ... Indian School Road, making it a great one stop destination for any immunological and ...
(Date:1/14/2019)... ... January 14, 2019 , ... Yes, the Millennials love their Bluetooth ... Council on Active Aging® (ICAA), new tech is also finding a home in senior ... , queried respondents from a variety of organizations that work with older adults about ...
(Date:1/14/2019)... Va. (PRWEB) , ... January 15, 2019 , ... Early ... on Jan. 22 , Risk management is just plain hard, complicated, conflicted, confusing. And ... the changes in the process are not intended as “major”, the new standard adds ...
(Date:1/14/2019)... ... January 14, 2019 , ... ... use and availability of VARIZIG® (Varicella Zoster Immune Globulin [Human]) for post-exposure ... ). In the update, the CDC notes that VARIZIG is commercially available from ...
(Date:1/14/2019)... ... ... Well Providers of 2019. , Acupuncture, Dr. Wai Chu - Homdel , ... Dr. Joanna Jodar - Somerset , Dr. Barbara Knoll - Lavallette , ... Dr. Robert J. Reinhardt - Pequannock , Dr. Sylvester Rich - Bound Brook , ...
Breaking Medicine News(10 mins):
(Date:1/7/2019)... ... January 07, 2019 , ... Dr. Joseph J. Rousso is a leading ... York City. He is certified by the American Board of Facial Plastic & Reconstructive ... both surgical and non-surgical procedures for the face and neck. Dr. Rousso is most ...
(Date:1/7/2019)... ... ... uBiome, the leader in microbial genomics, announced today the release of a new ... support in metabolizing alcohol. , In the process of metabolizing alcohol, your microbiome ... your body. The new story provides an individualized abundance of two groups of gut ...
(Date:1/7/2019)... ... ... and Ankle Podiatry has been ranked the number one choice for numerous years but has ... the best review average on both Google Reviews and Yelp. Let us show you why ... and Livingston St. Joseph Mercy Hospital for numerous years. And finally let us show you ...
Breaking Medicine Technology:
Cached News: